Lyfegen Unveils Generative AI to Transform Drug Contracting and Accelerate Patient Access
New AI capability enables structured, scalable contracting decisions amid accelerating global pricing complexity BASEL, Switzerland, March 3, 2026 /PRNewswire/ — Lyfegen, a global provider of innovative drug access, contracting and rebate management solutions, announced today the launch of its AI Contracting Companion. This AI solution is designed to support pharmaceutical organizations navigating through increasingly intricate…
